Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)-Reference-Cited by-同舟云学术

Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Published:2022-06-23 Issue:7 Volume:407 Page:3057-3067
ISSN:1435-2451
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Acs Miklos^ORCID,Gerken Michael,Gajic Ivana,Mayr Max,Zustin Jozef,Piso Pompiliu

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00423-022-02594-6.pdf

Reference37 articles.

1. Moolgavkar SH, Meza R, Turim J (2019) Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control 20(6):935–944. https://doi.org/10.1007/s10552-009-9328-9

2. Kim J, Bhagwandin S, Labow DM (2017) Malignant peritoneal mesothelioma: a review. Ann Transl Med 5(11):236. https://doi.org/10.21037/atm.2017.03.96

3. Cao C, Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P (2012) Sugarbaker PH (2012) Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol 23(6):1494–1498. https://doi.org/10.1093/annonc/mdr477

4. Tischoff I, Neid M, Neumann V, Tannapfel A (2011) Pathohistological diagnosis and differential diagnosis. Recent Results Cancer Res 189:57–78. https://doi.org/10.1007/978-3-642-10862-4_5

5. Lehnert M, Kraywinkel K, Heinze E, Wiethege T, Johnen G, Fiebig J, Brüning T, Taeger D (2017) Incidence of malignant mesothelioma in Germany 2009–2013. Cancer Causes Control 28(2):97–105. https://doi.org/10.1007/s10552-016-0838-y

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma;Journal of Surgical Oncology;2024-09-10

2. Nephrotoxicity Associated with Cytoreductive Surgery Combined with Cisplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignant Disease: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-28

3. Consensus Guideline for the Management of Patients with Peritoneal Mesothelioma;2024-04-13

4. Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC);Innovative Surgical Sciences;2024-03-01

5. Peritoneales Mesotheliom und Pseudomyxoma peritonei;best practice onkologie;2024-01-22